Market Cap 2.05B
Revenue (ttm) 427.54M
Net Income (ttm) -21.02M
EPS (ttm) N/A
PE Ratio 51.77
Forward PE 97.33
Profit Margin -4.92%
Debt to Equity Ratio 0.16
Volume 661,100
Avg Vol 803,880
Day's Range N/A - N/A
Shares Out 29.29M
Stochastic %K 3%
Beta 2.03
Analysts Strong Sell
Price Target $156.67

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
DevilKazuya
DevilKazuya Mar. 19 at 8:50 PM
$WGS $PHM looking plump...
0 · Reply
CarverX
CarverX Mar. 19 at 7:36 PM
$WGS Silent accumulation 🚀🚀🚀
0 · Reply
PencilNeckGeek
PencilNeckGeek Mar. 19 at 7:14 PM
$WGS Will be back over $90 soon imo
0 · Reply
Macarran
Macarran Mar. 19 at 9:17 AM
$WGS The rats keep abandoning ship https://www.quiverquant.com/stock/WGS/news/
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 19 at 2:08 AM
$WGS if you ever think about buying this stock I suggest listening to an earnings call first. That’ll put you off.
2 · Reply
gaineous
gaineous Mar. 18 at 9:38 PM
Smoke, Mirrors, & Worth another look. I’ve never met anyone who’s used $SFIX yet they claim they’re doing $1B in Rev.? Show me your books and walk me thru your ledgers. I liked it at $20 pre pandemic, kicked myself for not buying it when it hit $162 during the pandemic, wonder if anyone from TCV lost their job over it and don’t mind taking a flyer at $4.05 on $PTON Down -22% YoY after a strong Q4 w/guidance looking upwards; time to think about re-entering $WGS $XYZ looks deeply undervalued but like $DIS the boys down at Wall won’t show any love. Still, I like it and think it’s deeply undervalued (like GOOG); if they spun off Cash App that alone is worth 1/2 the current MCap. There’s no way the true value of C.App is priced in. Note to self: check price on deep ITM 2028 LEAP calls.
0 · Reply
CarverX
CarverX Mar. 18 at 8:44 PM
$WGS Added more shares here 🚀🚀🚀
0 · Reply
PencilNeckGeek
PencilNeckGeek Mar. 18 at 6:48 PM
$WGS Looks like a decent buy at this level
0 · Reply
Brokechump
Brokechump Mar. 15 at 10:05 PM
$WGS is this the old GENE stock?
0 · Reply
nucleotied
nucleotied Mar. 15 at 10:55 AM
$NTRA $WGS GeneDx first real competitor with deep pockets shows up. Natera has a genome, all the lives in the country in network, and more salespeople than GeneDX has employees (I think?).
0 · Reply
Latest News on WGS
GeneDx to Participate in Upcoming Investor Conferences

Feb 25, 2026, 8:30 AM EST - 24 days ago

GeneDx to Participate in Upcoming Investor Conferences


These Analysts Slash Their Forecasts On GeneDx After Q4 Results

Feb 24, 2026, 12:40 PM EST - 25 days ago

These Analysts Slash Their Forecasts On GeneDx After Q4 Results


GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript

Feb 23, 2026, 12:34 PM EST - 26 days ago

GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript


Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 3:03 PM EST - 2 months ago

Why is GeneDx stock crashing on Monday?


GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 30, 2025, 8:00 AM EST - 2 months ago

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference


6 Healthcare Stocks With Strong Upward Momentum

Nov 18, 2025, 12:59 PM EST - 4 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH MEDP


GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 3:41 PM EDT - 5 months ago

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript


GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth

Oct 27, 2025, 8:00 AM EDT - 5 months ago

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth


GeneDx's Blueprint For The Next Healthcare Revolution

Oct 15, 2025, 2:55 AM EDT - 5 months ago

GeneDx's Blueprint For The Next Healthcare Revolution


How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 3:17 PM EDT - 5 months ago

How GeneDX CEO Katherine Stueland is using AI to save lives


GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

Oct 14, 2025, 8:00 AM EDT - 5 months ago

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer


DevilKazuya
DevilKazuya Mar. 19 at 8:50 PM
$WGS $PHM looking plump...
0 · Reply
CarverX
CarverX Mar. 19 at 7:36 PM
$WGS Silent accumulation 🚀🚀🚀
0 · Reply
PencilNeckGeek
PencilNeckGeek Mar. 19 at 7:14 PM
$WGS Will be back over $90 soon imo
0 · Reply
Macarran
Macarran Mar. 19 at 9:17 AM
$WGS The rats keep abandoning ship https://www.quiverquant.com/stock/WGS/news/
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 19 at 2:08 AM
$WGS if you ever think about buying this stock I suggest listening to an earnings call first. That’ll put you off.
2 · Reply
gaineous
gaineous Mar. 18 at 9:38 PM
Smoke, Mirrors, & Worth another look. I’ve never met anyone who’s used $SFIX yet they claim they’re doing $1B in Rev.? Show me your books and walk me thru your ledgers. I liked it at $20 pre pandemic, kicked myself for not buying it when it hit $162 during the pandemic, wonder if anyone from TCV lost their job over it and don’t mind taking a flyer at $4.05 on $PTON Down -22% YoY after a strong Q4 w/guidance looking upwards; time to think about re-entering $WGS $XYZ looks deeply undervalued but like $DIS the boys down at Wall won’t show any love. Still, I like it and think it’s deeply undervalued (like GOOG); if they spun off Cash App that alone is worth 1/2 the current MCap. There’s no way the true value of C.App is priced in. Note to self: check price on deep ITM 2028 LEAP calls.
0 · Reply
CarverX
CarverX Mar. 18 at 8:44 PM
$WGS Added more shares here 🚀🚀🚀
0 · Reply
PencilNeckGeek
PencilNeckGeek Mar. 18 at 6:48 PM
$WGS Looks like a decent buy at this level
0 · Reply
Brokechump
Brokechump Mar. 15 at 10:05 PM
$WGS is this the old GENE stock?
0 · Reply
nucleotied
nucleotied Mar. 15 at 10:55 AM
$NTRA $WGS GeneDx first real competitor with deep pockets shows up. Natera has a genome, all the lives in the country in network, and more salespeople than GeneDX has employees (I think?).
0 · Reply
Exponential_increase
Exponential_increase Mar. 12 at 8:04 PM
$WGS Cathy Woods brought me back here.
0 · Reply
notreload_ai
notreload_ai Mar. 12 at 4:25 PM
$NTRA launches Zenith Genomics — its next-generation whole-genome sequencing test for faster rare disease diagnosis. $WGS shares drop as competition intensifies in the rare-disease market, which carries a $1 trillion economic burden. https://notreload.xyz/genedx-falls-after-natera-launches-zenith-genomics/
0 · Reply
resurrect_momo21
resurrect_momo21 Mar. 11 at 10:04 PM
$COCP as a ref $WGS Frost spin off one of the biggest winners ever and I even caught it even late GeneDx $1-160 in 13 months $20 mill to 4 billion view the chart great shit happens all the time in biotech.. its the low life bashers who are morons and mentally and physcially broke and have no life
0 · Reply
CarverX
CarverX Mar. 11 at 6:44 PM
$WGS More open market shares purchased by insiders (Stue and Feels)! 🚀🚀🚀 Let's go!! https://ir.genedx.com/node/11976/html https://ir.genedx.com/node/11981/html
0 · Reply
ZacksResearch
ZacksResearch Mar. 11 at 6:29 PM
Speeding up rare disease diagnosis just got real 🧬 $WGS is rolling out a Zevra-backed ExomeDx program for Niemann-Pick Type C, aiming to accelerate detection and feed new data into its Infinity dataset. See how this could reshape genetic testing 👉 https://www.zacks.com/stock/news/2882596/wgs-zevra-partner-to-launch-genetic-testing-for-niemann-pick-type-c?cid=sm-stocktwits-2-2882596-teaser-37058&ADID=SYND_STOCKTWITS_TWEET_2_2882596_TEASER_37058
0 · Reply
ZacksResearch
ZacksResearch Mar. 11 at 5:29 PM
$WGS drops 6% after announcing a new genetic testing program with Zevra Therapeutics. Is the market missing the long-term potential? 🧬 ⚠️ Shares down 29.5% over 6 months, despite a promising partnership to improve Niemann-Pick Disease diagnosis. 🔍 Sponsored initiative could bolster GeneDx’s role in rare disease diagnostics. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2882596/wgs-zevra-partner-to-launch-genetic-testing-for-niemann-pick-type-c?cid=sm-stocktwits-2-2882596-body-37059&ADID=SYND_STOCKTWITS_TWEET_2_2882596_BODY_37059
0 · Reply
CarverX
CarverX Mar. 9 at 8:03 PM
$WGS Eyeing 109 as next resistance 🚀🚀🚀
0 · Reply
11thestate
11thestate Mar. 9 at 11:50 AM
$WGS investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/cmls-investor-settlement
0 · Reply
Exponential_increase
Exponential_increase Mar. 8 at 1:37 AM
$WGS Is that a bullish continuation wedge?
1 · Reply
Doozio
Doozio Mar. 7 at 7:13 PM
$WGS weekly bullish engulfer at da bahhhhhtom. 🐒🍌🧠⏰♾️
0 · Reply
Jasooon
Jasooon Mar. 7 at 2:24 AM
$WGS Holy smokes
1 · Reply
Agost1990
Agost1990 Mar. 6 at 7:39 PM
$WGS April fool 🤷🏻‍♂️
0 · Reply